98%
921
2 minutes
20
Introduction: Oral food challenges are the gold standard for diagnosis and reactivity thresholds but are resource intensive and high risk for reactions. Limited data on factors associated with increased risk of positive oral food challenges exist. We aimed to assess factors associated with positive oral food challenges and create a model to predict cow milk oral food challenge outcomes.
Methods: Children aged 5-18 being considered for cow's milk oral immunotherapy underwent a single-blind, placebo-controlled food challenge to cow's milk, with either positive (reaction) or negative (tolerance) outcomes. Initial factors recorded included sex, age, history of asthma, eczema, allergic rhinitis, prior epinephrine use for cow's milk-induced reactions, skin prick test size, serum levels of immunoglobulin E antibodies to α-lactalbumin, β-lactoglobulin, and casein, and log-transformed values. Stepwise backward multivariate Firth bias-reduced logistic regression was used to create the final model, and performance was assessed with receiver operator characteristic curves.
Results: A total of 111 children underwent an oral food challenge, 103 patients reacted, and 8 tolerated the challenge. Univariate analysis showed skin prick test size, previous epinephrine use, history of asthma, and log-transformed α-lactalbumin, β-lactoglobulin, and casein were significantly associated with positive oral food challenge. The multivariate model included two factors: log-transformed casein (aOR 2.4; 95% CI: 1.4-5.9; p < 0.001) and previous epinephrine use (aOR 6.5; 95% CI: 1.2-68.0; p = 0.03). The final model showed good discriminatory performance (AUC 0.928; 95% CI: 0.83-0.98). In comparison, a univariate model using only the skin prick test (OR 1.44, 95% CI: 1.1-2.0; p = 0.002) had worse discriminatory performance (AUC 0.83; 95% CI: 0.64-0.93).
Conclusion: The study suggests that logistic multivariate models, including log-transformed casein and previous epinephrine use, may help predict oral food challenge outcomes in pediatric patients. Future studies are needed to validate this with larger datasets.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12013213 | PMC |
http://dx.doi.org/10.1159/000545027 | DOI Listing |
Allergy
September 2025
Department of Paediatrics, Division of Pneumology, Allergology, Infectious Diseases and Gastroenterology, Goethe University Frankfurt, Frankfurt am Main, Germany.
Premastication, or pre-chewing, of food as a feeding practice for infants has been practiced across cultures as an ancient evolutionary method. Whilst literature on the topic remains slim, the majority of existing research has highlighted the potential risks, such as transmission of infections. Although the concerns are valid, potential beneficial aspects have, until now, received less attention.
View Article and Find Full Text PDFJ Agric Food Chem
September 2025
College of Food Engineering and Nutritional Science, Shaanxi Normal University, Xi'an 710062, Shaanxi, China.
Diet regimes rich in fruits and vegetables have been adopted as effective strategies for the management of type 2 diabetes mellitus (T2DM). Here, we identified miR166e, a plant miRNA abundantly present in fruits and vegetables, as a functional agent that ameliorates T2DM in a mouse model. Orally administered miR166e oligomers passed through digestion, accumulated in the intestines at 14.
View Article and Find Full Text PDFTurk J Pharm Sci
September 2025
University of Maryland, Department of Pharmaceutical Sciences, Baltimore, USA.
Objectives: Norvir oral powder [ritonavir (RTV)] employs polyvinylpyrrolidone/vinyl acetate as the polymer to formulate an amorphous solid dispersion. Its oral absolute bioavailability is 70% in the fasted state, and it has negative food effects. The aim of this study was to perform in vitro dissolution of Norvir powder and Wagner-Nelson deconvolution of data under fasted, moderate fat, and high fat conditions in order to elucidate the relevance of dissolution testing.
View Article and Find Full Text PDFTurk J Pharm Sci
September 2025
Gate Institute of Pharmaceutical Sciences, Telangana, India.
Objectives: Bortezomib (BTZ) functions as an androgen receptor signalling inhibitor, is used for the treatment of prostate cancer, and has been sanctioned by the United States Food and Drug Administration. The medicinal applications of BTZ are impeded by low solubility, first-pass metabolism, and restricted bioavailability. This study aimed to develop and enhance polylactic acid-co-glycolic acid (PLGA) nanobubbles (NBs) as a sustained-release mechanism for BTZ, thereby augmenting stability and bioavailability.
View Article and Find Full Text PDFEur J Oral Sci
September 2025
State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Research Unit of Oral Carcinogenesis and Management, Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, People's Re
Oral lichen planus (OLP) is a chronic inflammatory disease of unknown aetiology, which is an oral potentially malignant disorder. Many investigators suggest that OLP may be a localized autoimmune response caused by cell-mediated autoimmunity to basal cells. However, it remains unclear whether allergens play a role in the pathogenesis of OLP.
View Article and Find Full Text PDF